You're reading: A leading life sciences legal practice launched under new brand Danevych.Law

Following 15 years of practicing life sciences a leading and internationally recognized legal practice launched under Danevych.Law brand name.

The team has been supporting global pharmaceutical companies (including 9 of global top 10 giants), clinical trials sponsors and CROs, medical devices companies, as well as leading industry associations (American Chamber of Commerce and European Business Association Healthcare Committees, and Association of Pharmaceutical Research and Development). AbbVie, AstraZeneca, EBRD, Gilead, Janssen, Lilly, Shire and many others are among Danevych.Law Clients.

The team of Danevych.Law is focused on Life Sciences and Healthcare areas, advising its Clients on regulatory, commercial, competition, intellectual property and white-collar crime, as well as representing them in disputes in the said areas. Additionally, the team is engaged into a number of policy dialogue and legislation development projects financed by international donors for the benefit of the Ministry of Health of Ukraine.

As a value driven law firm, Danevych.Law is committed to integrity, full transparency and compliance, and the rule of law.

Danevych.Law partnership is established as a result of Marchenko Danevych partnership termination.